Security National Financial (SNFCA) VP Quist exercises options and holds 19,942 shares
Rhea-AI Filing Summary
Security National Financial Corp director and Vice President/General Counsel Adam George Quist exercised stock options to acquire 8,934 shares of Class A Common Stock at $9.86 per share on April 18, 2026. Following this transaction, he directly holds 19,942 Class A shares.
The filing also lists a series of employee stock option grants on Class A and Class C Common Stock awarded between 2016 and 2025, with exercise prices ranging from $2.84 to $14.39 per share and expirations between 2026 and 2035. Footnotes note additional indirect holdings of 22,143 Class A shares in a Deferred Compensation Plan and 28,726 Class A shares in a 401(k) Retirement Savings Plan.
Positive
- None.
Negative
- None.
Insights
Routine option exercise and long-dated grants for SNFCA insider.
Adam George Quist, a director and Vice President/General Counsel of Security National Financial Corp, exercised options to acquire 8,934 Class A shares at $9.86 on April 18, 2026, increasing his direct Class A holdings to 19,942 shares.
The filing also details multiple employee stock option grants on Class A and Class C Common Stock from 2016 through 2025, with exercise prices between $2.84 and $14.39 and expirations extending to 2035. These are compensation-related awards rather than open-market purchases or sales.
Footnotes state that Quist also owns 22,143 Class A shares indirectly through a Deferred Compensation Plan and 28,726 Class A shares indirectly through a 401(k) Retirement Savings Plan. Overall, the activity appears to be standard equity compensation and option exercise, with no open-market buying or selling disclosed.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Class A Common Stock | 8,934 | $9.86 | $88K |
| Grant/Award | Employee Stock Option (right to buy) | 10,657 | $9.38 | $100K |
| Grant/Award | Employee Stock Option (right to buy) | 289,343 | $8.53 | $2.47M |
| Grant/Award | Employee Stock Option (right to buy) | 7,298 | $13.67 | $100K |
| Grant/Award | Employee Stock Option (right to buy) | 76,703 | $12.43 | $953K |
| Grant/Award | Employee Stock Option (right to buy) | 88,200 | $7.21 | $636K |
| Grant/Award | Employee Stock Option (right to buy) | 92,610 | $5.56 | $515K |
| Grant/Award | Employee Stock Option (right to buy) | 72,931 | $7.02 | $512K |
| Grant/Award | Employee Stock Option (right to buy) | 45,787 | $2.84 | $130K |
| Grant/Award | Employee Stock Option (right to buy) | 48,076 | $3.91 | $188K |
| Grant/Award | Employee Stock Option (right to buy) | 28,846 | $3.76 | $108K |
| Grant/Award | Employee Stock Option (right to buy) | 22,716 | $3.27 | $74K |
| Grant/Award | Employee Stock Option (right to buy) | 15,901 | $4.32 | $69K |
Footnotes (14)
- F1. Does not include 22,143 shares of Class A Common Stock owned indirectly by the reporting person in the Deferred Compensation Plan.
- F2. Does not include 28,726 shares of Class A Common Stock owned indirectly by the reporting person in the 401(k) Retirement Savings Plan.
- F3. This option was granted on December 2, 2016 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.
- F4. This option was granted on December 1, 2017 as an option to purchase either 15,000 shares of Class A Common Stock or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.
- F5. This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019 and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.
- F6. This option was granted on December 6, 2019 as an option to purchase either 35,000 shares of Class A Common Stock or 35,000 shares of Class C Common Stock at an exercise price of $5.46 per share. This option reflects the reporting person's election to have an option for 35,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.
- F7. This option was granted on March 27, 2020 as an option to purchase either 35,000 shares of Class A Common Stock or 35,000 shares of Class C Common Stock at an exercise price of $3.76 per share. This option reflects the reporting person's election to have an option for 35,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.
- F8. This option was granted on December 3, 2021 as an option to purchase either 60,000 shares of Class A Common Stock or 60,000 shares of Class C Common Stock at an exercise price of $8.62 per share. This option reflects the reporting person's election to have an option for 60,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.
- F9. This option was granted on December 2, 2022 as an option for either 80,000 shares of Class A Common Stock or 80,000 shares of Class C Common Stock at an exercise price of $6.48 per share. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on July 14, 2023, July 12, 2024 and July 18, 2025.
- F10. This option was granted on December 1, 2023 as an option for either 80,000 shares of Class A Common Stock or 80,000 shares of Class C Common Stock at an exercise price of $7.99 per share. This option reflects the reporting person's election to have an option for 80,000 Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2022 Equity Incentive Plan to reflect a 5% stock dividend paid on July 12, 2024 and July 18, 2025.
- F11. This option was granted on December 6, 2024 as an option for either 6,950 shares of Class A Common Stock or 6,950 shares of Class C Common Stock at an exercise price of $14.39 per share. This option reflects the reporting person's election to have an option for 6,950 Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2022 Equity Incentive Plan to reflect a 5% stock dividend paid on July 18, 2025.
- F12. This option was granted on December 6, 2024 as an option for either 73,050 shares of Class A Common Stock or 73,050 shares of Class C Common Stock at an exercise price of $13.08 per share. This option reflects the reporting person's election to have an option for 73,050 Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2022 Equity Incentive Plan to reflect a 5% stock dividend paid on July 18, 2025.
- F13. This option was granted on December 5, 2025 as an option for either 10,657 shares of Class A Common Stock or 10,657 shares of Class C Common Stock at an exercise price of $9.38 per share. This option reflects the reporting person's election to have an option for 10,657 Class A Common Stock. These options vest quarterly in equal installments, beginning on March 5, 2026.
- F14. This option was granted on December 5, 2025 as an option for either 289,343 shares of Class A Common Stock or 289,343 shares of Class C Common Stock at an exercise price of $8.53 per share. This option reflects the reporting person's election to have an option for 289,343 Class C Common Stock. These options vest quarterly in equal installments, beginning on March 5, 2026.
Key Figures
Key Terms
Employee Stock Option (right to buy) financial
Class C Common Stock financial
anti-dilution provisions financial
Deferred Compensation Plan financial
401(k) Retirement Savings Plan financial
stock dividend financial
AI-generated analysis. How Rhea-AI works. Not financial advice.